Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research

Patient-derived xenografts (PDXs) provide biologically relevant models and potential platforms for the development of treatment strategies for precision medicine in pancreatic cancer. Furthermore, circulating epithelial tumor cells (CETCs/CTCs) are released into the bloodstream by solid tumors and a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wagner, Benedikt Johannes (VerfasserIn) , Ettner-Sitter, Andreas (VerfasserIn) , Ihlo, Nicolas A. (VerfasserIn) , Behr, Merle (VerfasserIn) , Koelbl, Sebastian (VerfasserIn) , Brunner, Stefan M. (VerfasserIn) , Weber, Florian (VerfasserIn) , Rau, Bettina M. (VerfasserIn) , Schlitt, Hans J. (VerfasserIn) , Brochhausen, Christoph (VerfasserIn) , Schönmehl, Rebecca (VerfasserIn) , Artinger, Annalena (VerfasserIn) , Schott, Dorothea (VerfasserIn) , Pizon, Monika (VerfasserIn) , Pachmann, Katharina (VerfasserIn) , Aung, Thiha (VerfasserIn) , Haerteis, Silke (VerfasserIn) , Hackl, Christina (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 January 2025
In: Scientific reports
Year: 2025, Jahrgang: 15, Pages: 1-13
ISSN:2045-2322
DOI:10.1038/s41598-025-87054-z
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41598-025-87054-z
Verlag, kostenfrei, Volltext: http://www.nature.com/articles/s41598-025-87054-z
Volltext
Verfasserangaben:Benedikt J. Wagner, Andreas Ettner-Sitter, Nicolas A. Ihlo, Merle Behr, Sebastian Koelbl, Stefan M. Brunner, Florian Weber, Bettina M. Rau, Hans J. Schlitt, Christoph Brochhausen, Rebecca Schoenmehl, Annalena Artinger, Dorothea Schott, Monika Pizon, Katharina Pachmann, Thiha Aung, Silke Haerteis & Christina Hackl

MARC

LEADER 00000caa a2200000 c 4500
001 193290607X
003 DE-627
005 20250913141822.0
007 cr uuu---uuuuu
008 250811s2025 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41598-025-87054-z  |2 doi 
035 |a (DE-627)193290607X 
035 |a (DE-599)KXP193290607X 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wagner, Benedikt Johannes  |d 1993-  |e VerfasserIn  |0 (DE-588)1362114375  |0 (DE-627)1921177829  |4 aut 
245 1 0 |a Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research  |c Benedikt J. Wagner, Andreas Ettner-Sitter, Nicolas A. Ihlo, Merle Behr, Sebastian Koelbl, Stefan M. Brunner, Florian Weber, Bettina M. Rau, Hans J. Schlitt, Christoph Brochhausen, Rebecca Schoenmehl, Annalena Artinger, Dorothea Schott, Monika Pizon, Katharina Pachmann, Thiha Aung, Silke Haerteis & Christina Hackl 
264 1 |c 23 January 2025 
300 |b Illustrationen, Diagramme 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.08.2025 
520 |a Patient-derived xenografts (PDXs) provide biologically relevant models and potential platforms for the development of treatment strategies for precision medicine in pancreatic cancer. Furthermore, circulating epithelial tumor cells (CETCs/CTCs) are released into the bloodstream by solid tumors and a rare subpopulation—circulating cancer stem cells (cCSCs) - is considered to be responsible for recurrence and plays a key role in metastasis. For the identification of cCSCs, an innovative in vitro assay to generate tumorspheres was established in this study. The number of tumorspheres and CETCs/CTCs was analyzed perioperatively in 25 pancreatic cancer patients. Additionally, an individual in vivo chorioallantoic membrane (CAM) culture system was used to generate PDXs from these tumorspheres. While overall correlations of CETCs/CTCs with clinicopathological parameters did not reach statistical significance, a significant difference in the number of tumorspheres was observed between patient subgroups with lower and higher UICC stages. This finding underscores their potential as biomarkers, providing valuable insights into clinical decision-making and tumor progression. The application of tumorspheres on the CAM successfully established PDXs within 7 days. These xenografts closely resembled the histological features of the primary tumor. Hence, this model represents a novel and fast option for individualized testing of new therapies for PDAC. 
650 4 |a Cancer stem cells 
650 4 |a Cancer therapy 
650 4 |a Pancreatic cancer 
650 4 |a Stem-cell research 
650 4 |a Tumour biomarkers 
700 1 |a Ettner-Sitter, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Ihlo, Nicolas A.  |e VerfasserIn  |4 aut 
700 1 |a Behr, Merle  |e VerfasserIn  |4 aut 
700 1 |a Koelbl, Sebastian  |e VerfasserIn  |4 aut 
700 1 |a Brunner, Stefan M.  |e VerfasserIn  |4 aut 
700 1 |a Weber, Florian  |e VerfasserIn  |4 aut 
700 1 |a Rau, Bettina M.  |e VerfasserIn  |4 aut 
700 1 |a Schlitt, Hans J.  |e VerfasserIn  |4 aut 
700 1 |a Brochhausen, Christoph  |d 1969-  |e VerfasserIn  |0 (DE-588)123220963  |0 (DE-627)082421226  |0 (DE-576)293610843  |4 aut 
700 1 |a Schönmehl, Rebecca  |d 1991-  |e VerfasserIn  |0 (DE-588)1324477970  |0 (DE-627)1884336949  |4 aut 
700 1 |a Artinger, Annalena  |d 1997-  |e VerfasserIn  |0 (DE-588)1324478225  |0 (DE-627)1884337384  |4 aut 
700 1 |a Schott, Dorothea  |e VerfasserIn  |4 aut 
700 1 |a Pizon, Monika  |e VerfasserIn  |4 aut 
700 1 |a Pachmann, Katharina  |e VerfasserIn  |4 aut 
700 1 |a Aung, Thiha  |e VerfasserIn  |4 aut 
700 1 |a Haerteis, Silke  |e VerfasserIn  |4 aut 
700 1 |a Hackl, Christina  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Scientific reports  |d [London] : Springer Nature, 2011  |g 15(2025), Artikel-ID 2896, Seite 1-13  |h Online-Ressource  |w (DE-627)663366712  |w (DE-600)2615211-3  |w (DE-576)346641179  |x 2045-2322  |7 nnas  |a Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research 
773 1 8 |g volume:15  |g year:2025  |g elocationid:2896  |g pages:1-13  |g extent:13  |a Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research 
856 4 0 |u https://doi.org/10.1038/s41598-025-87054-z  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://www.nature.com/articles/s41598-025-87054-z  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250811 
993 |a Article 
994 |a 2025 
998 |g 1324477970  |a Schönmehl, Rebecca  |m 1324477970:Schönmehl, Rebecca  |d 60000  |d 63400  |e 60000PS1324477970  |e 63400PS1324477970  |k 0/60000/  |k 1/60000/63400/  |p 11 
998 |g 123220963  |a Brochhausen, Christoph  |m 123220963:Brochhausen, Christoph  |d 60000  |d 63400  |e 60000PB123220963  |e 63400PB123220963  |k 0/60000/  |k 1/60000/63400/  |p 10 
999 |a KXP-PPN193290607X  |e 475625652X 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"193290607X","id":{"eki":["193290607X"],"doi":["10.1038/s41598-025-87054-z"]},"name":{"displayForm":["Benedikt J. Wagner, Andreas Ettner-Sitter, Nicolas A. Ihlo, Merle Behr, Sebastian Koelbl, Stefan M. Brunner, Florian Weber, Bettina M. Rau, Hans J. Schlitt, Christoph Brochhausen, Rebecca Schoenmehl, Annalena Artinger, Dorothea Schott, Monika Pizon, Katharina Pachmann, Thiha Aung, Silke Haerteis & Christina Hackl"]},"relHost":[{"id":{"issn":["2045-2322"],"zdb":["2615211-3"],"eki":["663366712"]},"recId":"663366712","language":["eng"],"part":{"extent":"13","pages":"1-13","volume":"15","text":"15(2025), Artikel-ID 2896, Seite 1-13","year":"2025"},"disp":"Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer researchScientific reports","physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisherPlace":"[London] ; London","publisher":"Springer Nature ; Nature Publishing Group"}],"pubHistory":["1, article number 1 (2011)-"],"title":[{"title_sort":"Scientific reports","title":"Scientific reports"}],"note":["Gesehen am 12.07.24"]}],"physDesc":[{"extent":"13 S.","noteIll":"Illustrationen, Diagramme"}],"language":["eng"],"person":[{"family":"Wagner","given":"Benedikt Johannes","display":"Wagner, Benedikt Johannes","role":"aut"},{"display":"Ettner-Sitter, Andreas","given":"Andreas","family":"Ettner-Sitter","role":"aut"},{"role":"aut","family":"Ihlo","given":"Nicolas A.","display":"Ihlo, Nicolas A."},{"role":"aut","family":"Behr","given":"Merle","display":"Behr, Merle"},{"display":"Koelbl, Sebastian","family":"Koelbl","given":"Sebastian","role":"aut"},{"display":"Brunner, Stefan M.","given":"Stefan M.","family":"Brunner","role":"aut"},{"role":"aut","display":"Weber, Florian","family":"Weber","given":"Florian"},{"role":"aut","display":"Rau, Bettina M.","family":"Rau","given":"Bettina M."},{"role":"aut","display":"Schlitt, Hans J.","family":"Schlitt","given":"Hans J."},{"role":"aut","family":"Brochhausen","given":"Christoph","display":"Brochhausen, Christoph"},{"family":"Schönmehl","given":"Rebecca","display":"Schönmehl, Rebecca","role":"aut"},{"display":"Artinger, Annalena","given":"Annalena","family":"Artinger","role":"aut"},{"display":"Schott, Dorothea","given":"Dorothea","family":"Schott","role":"aut"},{"role":"aut","display":"Pizon, Monika","given":"Monika","family":"Pizon"},{"role":"aut","family":"Pachmann","given":"Katharina","display":"Pachmann, Katharina"},{"role":"aut","display":"Aung, Thiha","family":"Aung","given":"Thiha"},{"family":"Haerteis","given":"Silke","display":"Haerteis, Silke","role":"aut"},{"role":"aut","given":"Christina","family":"Hackl","display":"Hackl, Christina"}],"title":[{"title":"Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research","title_sort":"Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research"}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"23 January 2025"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 11.08.2025"]} 
SRT |a WAGNERBENEPATIENTDER2320